AU2746397A - Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers - Google Patents
Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancersInfo
- Publication number
- AU2746397A AU2746397A AU27463/97A AU2746397A AU2746397A AU 2746397 A AU2746397 A AU 2746397A AU 27463/97 A AU27463/97 A AU 27463/97A AU 2746397 A AU2746397 A AU 2746397A AU 2746397 A AU2746397 A AU 2746397A
- Authority
- AU
- Australia
- Prior art keywords
- diethanolamides
- fatty acids
- transdermal administration
- steroid hormones
- permeation enhancers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 239000003623 enhancer Substances 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- 239000003270 steroid hormone Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64037196A | 1996-04-30 | 1996-04-30 | |
US08640371 | 1996-04-30 | ||
PCT/US1997/007104 WO1997040792A1 (en) | 1996-04-30 | 1997-04-29 | Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2746397A true AU2746397A (en) | 1997-11-19 |
Family
ID=24567978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27463/97A Abandoned AU2746397A (en) | 1996-04-30 | 1997-04-29 | Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2746397A (en) |
WO (1) | WO1997040792A1 (en) |
ZA (1) | ZA973749B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6603751B1 (en) | 1998-02-13 | 2003-08-05 | Qualcomm Incorporated | Method and system for performing a handoff in a wireless communication system, such as a hard handoff |
US20030194033A1 (en) | 1998-05-21 | 2003-10-16 | Tiedemann Edward G. | Method and apparatus for coordinating transmission of short messages with hard handoff searches in a wireless communications system |
US6587446B2 (en) | 1999-02-11 | 2003-07-01 | Qualcomm Incorporated | Handoff in a wireless communication system |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
EP2157946A1 (en) * | 2007-06-06 | 2010-03-03 | Biohealth LLC | Pharmaceutical composition of a new system for vaginal release of steroids |
US8964692B2 (en) | 2008-11-10 | 2015-02-24 | Qualcomm Incorporated | Spectrum sensing of bluetooth using a sequence of energy detection measurements |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5560922A (en) * | 1986-05-30 | 1996-10-01 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process |
US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
DE69010076T2 (en) * | 1989-05-25 | 1994-12-08 | Takeda Chemical Industries Ltd | Transdermal therapeutic agent. |
US5252334A (en) * | 1989-09-08 | 1993-10-12 | Cygnus Therapeutic Systems | Solid matrix system for transdermal drug delivery |
US5314694A (en) * | 1990-10-29 | 1994-05-24 | Alza Corporation | Transdermal formulations, methods and devices |
US5460820B1 (en) * | 1993-08-03 | 1999-08-03 | Theratech Inc | Method for providing testosterone and optionally estrogen replacement therapy to women |
US5554381A (en) * | 1993-08-09 | 1996-09-10 | Cygnus, Inc. | Low flux matrix system for delivering potent drugs transdermally |
-
1997
- 1997-04-29 WO PCT/US1997/007104 patent/WO1997040792A1/en active Application Filing
- 1997-04-29 AU AU27463/97A patent/AU2746397A/en not_active Abandoned
- 1997-04-30 ZA ZA9703749A patent/ZA973749B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1997040792A1 (en) | 1997-11-06 |
ZA973749B (en) | 1998-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3654697A (en) | Transdermal application of naturally occurring steriod hormones | |
AU7998187A (en) | Transdermal administration of progesterone, estradiol esters, and mixtures thereof | |
AU2472997A (en) | A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof | |
AU3231300A (en) | Sitostanol formulation with emulsifier to reduce cholesterol absorption and method for preparing and use of same | |
AU7601998A (en) | Composition and methods for transdermal delivery of acid labile drugs | |
AU3008997A (en) | Antagonists of gonadotropin releasing hormone | |
AU5159490A (en) | Composition and method for administration of pharmaceutically active substances | |
AU4745390A (en) | Compositions for transdermal delivery of estradiol | |
CA2012875A1 (en) | Skin permeation enhancer compositions | |
AU4209400A (en) | Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs | |
AU1245097A (en) | Arrangement for specifying presentation of multimedia message components | |
IE894108L (en) | Sulfonic acid substituted aromatic steroids as inhibitors of¹steroid 5ó-reductase | |
AU3442497A (en) | Method of manufacturing an ester mixture | |
AU2334097A (en) | 4-spiroindoline piperidines promote release of growth hormone | |
PL345695A1 (en) | Estradiol-containing patch for transdermal administration of hormones | |
AU2922797A (en) | Novel steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs | |
AU1865199A (en) | Composition and method for dermal and transdermal administration of a cytokine | |
AU7358800A (en) | Compositions and methods for modification of skin lipid content | |
AU2746397A (en) | Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers | |
AU1262501A (en) | Compositions for transdermal and transmucosal administration of therapeutic agents | |
AU1429697A (en) | Systems and methods for the transdermal administration of androgenic agents | |
AU3772989A (en) | Penetration enhancers for transdermal delivery of systemic agent | |
CA2258681A1 (en) | Process for the preparation of 17-esters of 9.alpha.,21-dihalo-pregnane-11.beta.,17.alpha.diol-20-ones | |
AU7404196A (en) | Method for the preparation of steroid derivative ketal | |
AU2112995A (en) | Use of estrone derivatives as steroid sulphatase inhibitors |